Institute for Cancer Research

Kjetil Taskén
Institute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 380 employees. About 70% of the employees and projects are externally funded. Read more

See introductory video with welcome to the ICR 

See full video covering all of ICR and its Departments 

Publication overview

Annual reports

Current news and events

OUS Researcher Awards 2024Excellent researcher awards to Kjetil Taskén, Chloé B. Steen and Andreas Kleppe

Kjetil Taskén (left), Chloé Beate Steen and Andreas Kleppe.
Kjetil Taskén (left), Chloé Beate Steen and Andreas Kleppe.

Three Oslo University Hospital scientists received prestigous awards for their outstanding research on Friday June 14th.
The major prize - the "Excellent Researcher Award" - went to Kjetil Taskén.
Chloé Beate Steen and Andreas Kleppe both received the "Early Career Award".
The prize money - 400.000 and 200.000 NOK respectively - is earmarked for research activities.

The awards are distributed anually in order to honour excellent scientific work. The awarding process is organized by the hospital's research committee, while an external Scientific Advisory Board has evaluated the candidates. 

Call for applications - deadline September 4thRegional research funding for 2025 from Helse Sør-Øst

Helse Sør-Øst RHF announces NOK 130 million for health research in the region. In addition, up to NOK 10 million will be allocated targeted funding within prioritised thematic areas, and up to NOK 5 million will be allocated strategic research funding to non-university hospitals.

The application deadline is Wednesday 4th September 2024 at 16:00

For 2025, research funding is available within the following application categories: 

  • Doctoral grants 
  • Postdoctoral grants 
  • Open project support 

Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2023

In order to stimulate excellent research and draw attention to the hospital's research activity, Oslo University Hospital rewards outstanding publications every half-year.

Six research groups were awarded for their excellent papers published the second half-year of 2023 during a ceremony on June 7th. Each group received NOK 50.000 earmarked for further research, and the prize winners gave short presentations of their main findings.

Anita Sveen’s project group publish in Nature Communications

The Computational Oncology project group, led by Anita Sveen, has in collaboration with additional members of the Lothe group and clinical partners at OUH published a study on transcriptomic tumor heterogeneity of colorectal cancers.
Gene expression analysis of approximately 1,100 samples from primary tumors and liver metastases of 700 patients treated at OUH was used to define patterns of heterogeneous and uniform expression across tumor regions.

The Annual report from Institute for Cancer Research is published

The annual report for 2023 from the Institute for Cancer Research at Oslo University Hospital is now available online. The eleven key topics of the report describe the work and output from ICR in 2023. Alongside outstanding research and key figures, the report includes information about how we work with recruitment, training, and career development, translation and innovation, dissemination, and public outreach, and collaboration in Norway and abroad.

Our 377 employees in 6 research departments, 26 research groups, 29 project groups, and 6 core facility units represent a vibrant research environment producing high-quality research from basic research to clinical trials.

Participants wanted forPhoto project to portray people with cancer

Sigrid S. Skånland
Sigrid S. Skånland

Cancer patients are often shown as stereotypes in the media – a person without hair in a hospital bed. Sigrid S. Skånland wants to change this by showing the diversity of people with cancer through portraits. 

Sigrid S. Skånland is a researcher and project leader at the Institute for Cancer Research. She was awarded the “Researcher of the Year” prize in 2023 for the work she does on developing and implementing precision medicine for patients with blood cancer. She has spent the last decade studying patient cells in the lab and says she would like to interact more with the patients.